D.C. Council Grants Initial Approval To Pharmaceutical Sales Representative Licensing Bill

Main Category: Pharma Industry / Biotech Industry
Also Included In: Pharmacy / Pharmacist;  Primary Care / General Practice
Article Date: 14 Dec 2007 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:3 stars

3 (3 votes)


The Washington, D.C., Council on Tuesday voted 7-6 to grant initial approval for legislation that would require pharmaceutical sales representatives to be licensed, the Washington Post reports. Under the legislation, representatives would be required to have a college degree, sign a code of ethics and be subject to regulation by a pharmacy board. Representatives also would be prohibited from using titles that falsely imply they are licensed to practice pharmacy, medicine or nursing. The bill also includes a ban on a practice known as data mining, where drug makers use doctors' prescribing data without their knowledge to develop marketing strategies.

Industry lobbyists urged the council to reject the bill, saying that federal laws and American Medical Association policies provide adequate oversight of drug representatives. However, council Health Committee Chair David Catania said those laws and policies do not stop representatives from misinforming physicians. If approved, the district would be the first jurisdiction in the U.S. to license pharmaceutical sales representatives, the Post reports.

Pharmaceutical Research and Manufacturers of America Senior Vice President Ken Johnson in a statement on Tuesday said, "The bill passed by the council puts the city into a regulatory arena that has been effectively addressed by federal laws and federal government agencies for years." Johnson added that the legislation "creates unnecessary financial burdens for the District of Columbia at a time when the money would be better spent addressing a wide array of health care challenges confronting the city." The council will vote on final approval of the bill on Jan. 8, 2008 (Stewart, Washington Post, 12/12).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "D.C. Council Grants Initial Approval To Pharmaceutical Sales Representative Licensing Bill." Medical News Today. MediLexicon, Intl., 14 Dec. 2007. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/91780.php>

APA
Kaiser. (2007, December 14). "D.C. Council Grants Initial Approval To Pharmaceutical Sales Representative Licensing Bill." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/91780.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »